Prognostic value of Child-Turcotte criteria in medically treated cirrhosis.
The Child- Turcotte criteria (CTC) (based on serum bilirubin and albumin, ascites, neurological disorder and nutrition) are established prognostic factors in patients with cirrhosis having portacaval shunt surgery. The objective of this study was to evaluate the prognostic value of CTC in conservatively treated cirrhosis. Patients (n = 245) with histologically verified cirrhosis from a control group of a controlled clinical trial were studied. Data at entry into the trial were used to classify patients according to CTC. Survival curves for up to 16 years were made, and survival rates were compared using the log-rank test. Survival decreased significantly with increasing degree of abnormality (A----B----C) of albumin (p less than 0.001), ascites (p less than 0.001), bilirubin (p = 0.02) and nutritional status (p = 0.03). Survival was insignificantly influenced by neurological status (p = 0.11) probably because none of the patients had hepatic coma at entry into the trial. The five variables in CTC were combined to a score. With increasing score, the median survival time decreased from 6.4 years (score 5) to 2 months (scores 12 or more). Furthermore, the mortality from hepatic failure, gastrointestinal bleeding or hepatocellular carcinoma increased significantly with increasing score. CTC provide valuable and easily obtainable prognostic information in cirrhosis. However, CTC are inferior to a prognostic index based on multivariate analysis of prognostic factors.
D000206:Actuarial Analysis; D000704:Analysis of Variance; D001663:Bilirubin / Q000097:blood; D004032:Diet; D005500:Follow-Up Studies; D006305:Health Status Indicators; D006801:Humans; D008103:Liver Cirrhosis / Q000145:classification / Q000188:drug therapy / Q000401:mortality*; D009461:Neurologic Manifestations; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012709:Serum Albumin / Q000032:analysis
D012709:Serum Albumin; D001663:Bilirubin; D011241:Prednisone